Biochemical markers of the L-arginine-nitric oxide pathway in the aqueous humour in glaucoma patients

被引:34
|
作者
Kotikoski, H
Moilanen, E
Vapaatalo, H
Aine, E
机构
[1] Tampere Univ Hosp, Dept Ophthalmol, FIN-33521 Tampere, Finland
[2] Univ Helsinki, Inst Biomed, Helsinki, Finland
[3] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland
来源
ACTA OPHTHALMOLOGICA SCANDINAVICA | 2002年 / 80卷 / 02期
关键词
glaucoma; nitric oxide; aqueous humour; serum; pseudoexfoliation; blood pressure;
D O I
10.1034/j.1600-0420.2002.800214.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To study the role of the L-arginine-nitric oxide (NO) pathway in aqueous humour dynamics by measuring nitrate, nitrite and cyclic (cGMP) levels in guanosine 3',5'-monophosphate the aqueous humour of glaucomatous and non-glaucomatous cataract patients. Methods: The study involved 38 glaucoma patients undergoing unilateral cataract surgery in the glaucomatous eye and 38 cataract control patients matched for sex, age, smoking habits and organic nitrate medication. All subjects underwent ophthalmic examination, and blood pressure was measured preoperatively. Nitrite, nitrate and cGMP levels were measured in aqueous humour and serum. Results: The NOx (nitrite + nitrate), nitrite and cGMP concentrations in the aqueous humour were slightly higher in the glaucoma patients than in the control patients, but the differences did not reach statistical significance. The levels of cGMP in serum were higher in the glaucoma patients (P = 0.053). The subgroup of glaucoma patients with pseudoexfoliation had lower NOx and nitrite values in the aqueous humour (P = 0.046 and P = 0.345, respectively) than the matched controls, while cGMP levels were higher (P = 0.043). Levels of NOx and nitrite in the aqueous humour were higher in patients using oral nitroglycerin (P = 0.062 and P = 0.042, respectively) than in patients without this medication. Blood pressure was higher in the glaucoma patients, with a mean of 165/89 mmHg as compared to 153/81 mmHg in the controls (P-values 0.071/0.008). Conclusions: No differences in NO metabolites were found between glaucoma and control patients. However, any real changes may have been disguised by optimal medication of glaucoma. Low NOx and high cGMP levels in the aqueous humour of pseudoexfoliation patients warrant further evaluation in a larger study.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 50 条
  • [41] The l-arginine-nitric oxide pathway: A potential therapeutic target in dengue haemorhagic fever
    Achike, Froncis I.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (10) : 1135 - 1136
  • [42] L-arginine-nitric oxide pathway in end-stage renal disease - Discussion
    Prabhakar, SS
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (01) : 195 - 198
  • [43] Role of L-arginine-nitric oxide pathway in normal pregnancy and pre-eclampsia
    Lopez-Jaramillo, P
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 523 : 43S - 44S
  • [44] THE ROLE OF THE L-ARGININE-NITRIC OXIDE PATHWAY IN RELAXATION OF THE OPOSSUM LOWER ESOPHAGEAL SPHINCTER
    TOTTRUP, A
    KNUDSEN, MA
    GREGERSEN, H
    BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (01) : 113 - 116
  • [45] Possible involvement of l-arginine-nitric oxide pathway in the antidepressant activity of Auraptene in mice
    Hossein Amini-Khoei
    Shakiba Nasiri Boroujeni
    Forough Maghsoudi
    Mohammad Rahimi-Madiseh
    Elham Bijad
    Mohammadtaghi Moradi
    Zahra Lorigooini
    Behavioral and Brain Functions, 18
  • [46] L-Arginine Inhibits Apoptosis of Ovine Intestinal Epithelial Cells through the L-Arginine-Nitric Oxide Pathway
    Zhang, Hao
    Zhao, Fangfang
    Peng, Along
    Guo, Shuang
    Wang, Mengzhi
    Elsabagh, Mabrouk
    Loor, Juan J.
    Wang, Hongrong
    JOURNAL OF NUTRITION, 2020, 150 (08): : 2051 - 2060
  • [47] The Role of the L-Arginine-Nitric Oxide Molecular Pathway in Autosomal Dominant Polycystic Kidney Disease
    Ene, Corina Daniela
    Penescu, Mircea
    Nicolae, Ilinca
    Capusa, Cristina
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (03):
  • [48] Increased contribution of L-arginine-nitric oxide pathway in aorta of mice lacking the gene for vimentin
    Zhang, J
    Henrion, D
    Ebrahimian, T
    Benessiano, J
    Colucci-Guyon, E
    Langa, F
    Lévy, BI
    Boulanger, CM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (04) : 552 - 560
  • [49] Venlafaxine prevents morphine antinociceptive tolerance: The role of neuroinflammation and the L-arginine-nitric oxide pathway
    Mansouri, Mohammad Taghi
    Naghizadeh, Bahareh
    Ghorbanzadeh, Behnam
    Alboghobeish, Soheila
    Amirgholami, Neda
    Houshmand, Gholamreza
    Cauli, Omar
    EXPERIMENTAL NEUROLOGY, 2018, 303 : 134 - 141
  • [50] Modulating the L-arginine-nitric oxide pathway in septic shock: Choosing the proper point of attack
    Fink, MP
    CRITICAL CARE MEDICINE, 1999, 27 (09) : 2019 - 2022